MedPath

Multivitamin

59088-018 Multivitamin Chewable Tablets

Approved
Approval ID

353453e2-1f60-24ea-e063-6394a90a251e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 15, 2025

Manufacturers
FDA

PureTek Corporation

DUNS: 785961046

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Multivitamin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59088-018
Product Classification
G
Generic Name
Multivitamin
Product Specifications
Route of AdministrationORAL
Effective DateMay 15, 2025
FDA Product Classification

INGREDIENTS (19)

SUCROSEInactive
Code: C151H8M554
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
D&C RED NO. 27Inactive
Code: 2LRS185U6K
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
VITAMIN AActive
Quantity: 750 ug in 1 1
Code: 81G40H8B0T
Classification: ACTIB
ASCORBIC ACIDActive
Quantity: 24 mg in 1 1
Code: PQ6CK8PD0R
Classification: ACTIB
SODIUM ASCORBATEActive
Quantity: 36 mg in 1 1
Code: S033EH8359
Classification: ACTIM
CHOLECALCIFEROLActive
Quantity: 10 ug in 1 1
Code: 1C6V77QF41
Classification: ACTIB
PYRIDOXINE HYDROCHLORIDEActive
Quantity: 1.05 mg in 1 1
Code: 68Y4CF58BV
Classification: ACTIM
THIAMINE MONONITRATEActive
Quantity: 1.05 mg in 1 1
Code: 8K0I04919X
Classification: ACTIR
RIBOFLAVINActive
Quantity: 1.2 mg in 1 1
Code: TLM2976OFR
Classification: ACTIB
NIACINActive
Quantity: 13.5 mg in 1 1
Code: 2679MF687A
Classification: ACTIB
LEVOMEFOLATE CALCIUMActive
Quantity: 1000 ug in 1 1
Code: A9R10K3F2F
Classification: ACTIB
METHYLCOBALAMINActive
Quantity: 4.5 ug in 1 1
Code: BR1SN1JS2W
Classification: ACTIB
ASPARTAMEInactive
Code: Z0H242BBR1
Classification: IACT
.ALPHA.-TOCOPHEROL ACETATE, DL-Active
Quantity: 10 mg in 1 1
Code: WR1WPI7EW8
Classification: ACTIM

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 5/15/2025

Multivitamin Chewable Tablets

Manufactured in the USA by:

PureTek Corporation

Panorama City, CA 91402

Questions? Call toll-free:

1-877-921-7873

label

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 5/15/2025

INDICATIONS AND USAGE

Multivitamin Chewable Tablets is indicated to provide significant amounts of Vitamins A, C, D, E, thiamine, riboflavin, niacin, vitamin B6, vitamin B12, and folate to supplement the diet, and to help assure that nutritional deficiencies of these vitamins will not develop.

Contraindications:

This product is contraindicated in patients with known hypersensitivity to any of its ingredients.

ADVERSE REACTIONS SECTION

LOINC: 34084-4Updated: 5/15/2025

Adverse Reactions:

Folate: Allergic sensitizations has been reported following both oral and parenteral administration of folate. Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein. However, allergic and idiosyncratic reactions are possible at lower levels.

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 5/15/2025

HOW SUPPLIED

Multivitamin chewable tablets are light purple with speckles, grape flavor, un-scored, round tablets. Available on prescription only in bottle of 30 tablets – NDC 59088-018-54. Dispense in a tight, light resistant container with a child resistant closure as defined in the USP/NF. All prescription substitutions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product.

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 5/15/2025

STORAGE

Do not use if bottle seal is broken. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 7/25/2022

DOSAGE AND ADMINISTRATION

One tablet daily, to be dissolved in the mouth or chewed before swallowing.

DESCRIPTION SECTION

LOINC: 34089-3Updated: 5/15/2025

Each Chewable Tablet Contains:

Vitamin A (as Retinyl Acetate).................................... 750 mcg RAE

Vitamin C (as Sodium Ascorbate and Ascorbic Acid).............. 60 mg

Vitamin D3 (as Cholecalciferol)............................................ 10 mcg

Vitamin E (as DL-Alpha Tocopheryl Acetate)........................ 10 mg

Thiamin (as Thiamine Mononitrate).................................... 1.05 mg

Riboflavin............................................................................... 1.2 mg

Niacin (as Niacinamide)....................................................... 13.5 mg

Vitamin B6 (as Pyridoxine Hydrochloride).......................... 1.05 mg

Folate (as L-5-Methyltetrahydrofolate calcium salt)…1700 mcg DFE

(1000 mcg as L-5-Methylfolate)

Vitamin B12 (as Methylcobalamin)..................................... 4.5 mcg

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 5/15/2025

Other Ingredients:

Aspartame, Croscarmellose Sodium, Grape Flavor, Magnesium Stearate (vegetable source), Microcrystalline Cellulose, Stearic Acid (vegetable source), Sucrose, CI 45410 (Red 27 Lake), CI 42090 (FD&C Blue No. 1 Aluminum Lake).

Phenylketonurics: Phenylalanine 3.0 mg Per Tablet.

WARNINGS SECTION

LOINC: 34071-1Updated: 5/15/2025

WARNING

Keep out of the reach of children. In case of accidental overdose, seek professional assistance or contact a Poison Control Center immediately.

**CAUTION:**Should be chewed.

PRECAUTIONS SECTION

LOINC: 42232-9Updated: 5/15/2025

PRECAUTIONS

Folate in doses above 0.1 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive. There is a potential danger in administering folate to patients with undiagnosed anemia, since folate may obscure the diagnosis of pernicious anemia by alleviating the hematologic manifestations of the disease while allowing the neurologic complications to progress. This may result in severe nervous system damage before the correct diagnosis is made. Adequate doses of vitamin B12 may prevent, halt, or improve the neurologic changes caused by pernicious anemia.

The patient’s medical conditions and consumption of other drugs, herbs, and/or supplements should be considered.

Use only under the direction of a licensed healthcare practitioner. Call your doctor about side effects. To report side effects, callPureTek Corporation at1-877-921-7873 or** FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.**

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.